Joel Linden Email
Chief Scientific Officer . Adovate
How to contact Joel Linden
Join and see Joel's contact info for free!Current Roles
Employees:
27Revenue:
$5.4MAbout
Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.Adovate Address
null, null